The endocannabinoid system: A new entry in remote cell death mechanisms

M. T. Viscomi, S. Oddi, L. Latini, E. Bisicchia, M. Maccarrone, M. Molinari

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Functional impairment after development of focal CNS lesions depends highly on damage that occurs in regions that are remote but functionally connected to the primary lesion site. These remote effects include cell death and structural changes, and they are important predictors of outcome in several pathologies, such as stroke, multiple sclerosis, and brain trauma. A greater understanding of the neuropathological mechanisms that exist in regions that are remote from focal primary lesions is therefore essential for the development of neuroprotective strategies.Endocannabinoids constitute a novel class of lipids that regulate mammalian cell apoptosis and the pathogenesis of neuroinflammatory and neurodegenerative diseases. In addition to well-described pharmacological actions in the brain, such as analgesia, hypokinesia, and hypothermia, endocannabinoids have been recently reported to control neuronal cell fate in various neuropathological conditions. Following brain injury, endocannabinoids are released, causing both protective and degenerative effects. Several hypotheses have been proposed to explain their role, but the mechanisms by which they act are largely unknown. New evidence indicates that the endocannabinoid system is a key participant in the determination of cell fate in remote cell death and its associated mechanisms. This review addresses recent findings on endocannabinoid function, focusing particularly on the relationships between the nitrergic, purinergic, and endocannabinoid systems.

Original languageEnglish
Pages (from-to)56-65
Number of pages10
JournalExperimental Neurology
Volume224
Issue number1
DOIs
Publication statusPublished - Jul 2010

Fingerprint

Endocannabinoids
Cell Death
Hypokinesia
Multiple Trauma
Hypothermia
Neurodegenerative Diseases
Analgesia
Brain Injuries
Multiple Sclerosis
Stroke
Pharmacology
Apoptosis
Pathology
Lipids
Brain

Keywords

  • Apoptosis
  • Axotomy
  • Cerebellum
  • Necrosis
  • Neurodegeneration
  • Neuroprotection
  • NOS
  • Purinergic

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

The endocannabinoid system : A new entry in remote cell death mechanisms. / Viscomi, M. T.; Oddi, S.; Latini, L.; Bisicchia, E.; Maccarrone, M.; Molinari, M.

In: Experimental Neurology, Vol. 224, No. 1, 07.2010, p. 56-65.

Research output: Contribution to journalArticle

Viscomi, M. T. ; Oddi, S. ; Latini, L. ; Bisicchia, E. ; Maccarrone, M. ; Molinari, M. / The endocannabinoid system : A new entry in remote cell death mechanisms. In: Experimental Neurology. 2010 ; Vol. 224, No. 1. pp. 56-65.
@article{b4adaab2db4143a1a410bc61cfcdc872,
title = "The endocannabinoid system: A new entry in remote cell death mechanisms",
abstract = "Functional impairment after development of focal CNS lesions depends highly on damage that occurs in regions that are remote but functionally connected to the primary lesion site. These remote effects include cell death and structural changes, and they are important predictors of outcome in several pathologies, such as stroke, multiple sclerosis, and brain trauma. A greater understanding of the neuropathological mechanisms that exist in regions that are remote from focal primary lesions is therefore essential for the development of neuroprotective strategies.Endocannabinoids constitute a novel class of lipids that regulate mammalian cell apoptosis and the pathogenesis of neuroinflammatory and neurodegenerative diseases. In addition to well-described pharmacological actions in the brain, such as analgesia, hypokinesia, and hypothermia, endocannabinoids have been recently reported to control neuronal cell fate in various neuropathological conditions. Following brain injury, endocannabinoids are released, causing both protective and degenerative effects. Several hypotheses have been proposed to explain their role, but the mechanisms by which they act are largely unknown. New evidence indicates that the endocannabinoid system is a key participant in the determination of cell fate in remote cell death and its associated mechanisms. This review addresses recent findings on endocannabinoid function, focusing particularly on the relationships between the nitrergic, purinergic, and endocannabinoid systems.",
keywords = "Apoptosis, Axotomy, Cerebellum, Necrosis, Neurodegeneration, Neuroprotection, NOS, Purinergic",
author = "Viscomi, {M. T.} and S. Oddi and L. Latini and E. Bisicchia and M. Maccarrone and M. Molinari",
year = "2010",
month = "7",
doi = "10.1016/j.expneurol.2010.03.023",
language = "English",
volume = "224",
pages = "56--65",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The endocannabinoid system

T2 - A new entry in remote cell death mechanisms

AU - Viscomi, M. T.

AU - Oddi, S.

AU - Latini, L.

AU - Bisicchia, E.

AU - Maccarrone, M.

AU - Molinari, M.

PY - 2010/7

Y1 - 2010/7

N2 - Functional impairment after development of focal CNS lesions depends highly on damage that occurs in regions that are remote but functionally connected to the primary lesion site. These remote effects include cell death and structural changes, and they are important predictors of outcome in several pathologies, such as stroke, multiple sclerosis, and brain trauma. A greater understanding of the neuropathological mechanisms that exist in regions that are remote from focal primary lesions is therefore essential for the development of neuroprotective strategies.Endocannabinoids constitute a novel class of lipids that regulate mammalian cell apoptosis and the pathogenesis of neuroinflammatory and neurodegenerative diseases. In addition to well-described pharmacological actions in the brain, such as analgesia, hypokinesia, and hypothermia, endocannabinoids have been recently reported to control neuronal cell fate in various neuropathological conditions. Following brain injury, endocannabinoids are released, causing both protective and degenerative effects. Several hypotheses have been proposed to explain their role, but the mechanisms by which they act are largely unknown. New evidence indicates that the endocannabinoid system is a key participant in the determination of cell fate in remote cell death and its associated mechanisms. This review addresses recent findings on endocannabinoid function, focusing particularly on the relationships between the nitrergic, purinergic, and endocannabinoid systems.

AB - Functional impairment after development of focal CNS lesions depends highly on damage that occurs in regions that are remote but functionally connected to the primary lesion site. These remote effects include cell death and structural changes, and they are important predictors of outcome in several pathologies, such as stroke, multiple sclerosis, and brain trauma. A greater understanding of the neuropathological mechanisms that exist in regions that are remote from focal primary lesions is therefore essential for the development of neuroprotective strategies.Endocannabinoids constitute a novel class of lipids that regulate mammalian cell apoptosis and the pathogenesis of neuroinflammatory and neurodegenerative diseases. In addition to well-described pharmacological actions in the brain, such as analgesia, hypokinesia, and hypothermia, endocannabinoids have been recently reported to control neuronal cell fate in various neuropathological conditions. Following brain injury, endocannabinoids are released, causing both protective and degenerative effects. Several hypotheses have been proposed to explain their role, but the mechanisms by which they act are largely unknown. New evidence indicates that the endocannabinoid system is a key participant in the determination of cell fate in remote cell death and its associated mechanisms. This review addresses recent findings on endocannabinoid function, focusing particularly on the relationships between the nitrergic, purinergic, and endocannabinoid systems.

KW - Apoptosis

KW - Axotomy

KW - Cerebellum

KW - Necrosis

KW - Neurodegeneration

KW - Neuroprotection

KW - NOS

KW - Purinergic

UR - http://www.scopus.com/inward/record.url?scp=77953808957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953808957&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2010.03.023

DO - 10.1016/j.expneurol.2010.03.023

M3 - Article

C2 - 20353775

AN - SCOPUS:77953808957

VL - 224

SP - 56

EP - 65

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -